Aurinia Pharmaceuticals (AUPH) Chief Executive Kevin Tang purchased about 815,000 shares in the company for a combined $12.5 million, a Wednesday filing with the US Securities and Exchange Commission showed.
Shares were acquired between May 29 and June 2 across several transactions at prices ranging from $15.28 to $15.35 apiece, the filing showed.